• Follow the Money: Personalized Therapy for Colorectal Cancer, Methyl-Copying PCR Platform, More

    Feb 25 | Diagnostics World News | Neogap Therapeutics advances their ongoing clinical study for personalized therapy for advanced colorectal cancer; Syndex Bio introduced its proprietary mcPCR (methyl-copying PCR) platform; and more. More

  • Precision Medicine Needs Precision Engineered Diagnostic Systems

    Feb 20 | Diagnostics World News | Precision medicine is often described as the future of healthcare. But from an engineering standpoint, it’s already here, and it’s forcing diagnostic instruments to evolve faster than most development cycles are comfortable with. We’re asking instruments to do more than confirm a suspected diagnosis. We’re asking them to deliver specificity, speed, and confidence in environments that aren’t always predictable. That’s a major shift from the days when “good enough” screening could drive clinical decisions. More

  • Clock Model Predicts When Alzheimer’s Symptoms Will Appear

    Feb 19 | Diagnostics World News | Researchers from the Foundation for the National Institutes of Health (FNIH), Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and more have published results of a study using a single plasma biomarker sample to estimate not only the probability of an Alzheimer’s Disease diagnosis, but when symptoms will develop. More

  • PacBio’s Rare Disease, ASO Push

    Feb 17 | Diagnostics World News | PacBio has announced several rare disease genomics programs so far this year. The most recent partner organizations include iHope, N-Lorem, EspeRare, UW Medicine, and Seattle Children’s Hospital. More

  • Zentropy: A New Framework to Transform Medical Prediction

    Feb 13 | Diagnostics World News | A research team at Penn State is reshaping the future of diagnostics by embedding the laws of thermodynamics directly into artificial intelligence (AI). Their framework, called zentropy-embedded neural networks (ZENN) promises to improve how clinicians interpret complex, multi-source diagnostic data, from brain scans to blood tests. More

  • UK Consortium Builds Cancer Dataset and AI Models with 10x Xenium Spatial Platform

    Feb 06 | Diagnostics World News | PharosAI, a research consortium of four UK institutions, plans to use the 10x Genomics Xenium spatial platform to build one of the world's most comprehensive multimodal cancer datasets and pair them with advanced AI models and analytical capabilities. They plan to democratize access to these datasets, ensuring they are securely available to a broad community of researchers and innovators. More

  • Parkinson’s Disease Can Now Be Identified in Blood

    Feb 05 | Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more. More

  • Study Suggests ‘Brain is to Blame’ for High Blood Pressure

    Feb 03 | Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more. More

  • Follow the Money: Cell Stress Sensing Platform, Next-Gen Precision Diagnostics Platform, Novel Proximity-Modulating Therapeutics

    Jan 28 | Diagnostics World News | Soley Therapeutics will advance its proprietary cell stress sensing platform; Precede Biosciences’s platform aims to meet rapidly growing demand from developers of next-generation precision medicines; Proxima will accelerate the advancement of first-in-class proximity-modulating therapeutics; and more. More

  • Autism Early Risk Identifier, Increased Demand for Molecular Testing, Collaboration for Colorectal Cancer Detection

    Jan 27 | Diagnostics World News | NeuroQure has launched ASD Insight, a first-of-its-kind test designed to identify autism risk as early as birth; Cytespace expanded its molecular testing to meet increasing demands across Sub-Saharan Africa; Daisy Genomics and New Day Diagnostics have entered a collaboration with the University of Tennessee and the East Tennessee Health Innovation Alliance; and more. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more